Combination of brentuximab‐vedotin and ifosfamide, carboplatin, etoposide in relapsed/refractory peripheral T‐cell lymphoma - Sorbonne Université
Journal Articles European Journal of Haematology Year : 2020

Combination of brentuximab‐vedotin and ifosfamide, carboplatin, etoposide in relapsed/refractory peripheral T‐cell lymphoma

Abstract

Objectives Relapsed/refractory peripheral T‐cell lymphomas (PTCL) have a poor prognosis. We aimed at assessing efficacy of ifosfamide, carboplatin, etoposide (ICE) regimen, a known therapeutic option, to which we added brentuximab‐vedotin (BV). Methods In this study, we retrospectively analyzed patients with PTCL treated with BV‐ICE in our center between July 2014 and March 2018. Results Fourteen patients received BV‐ICE. Median age was 62 years (range, 31‐73). Main histological subtypes were PTCL‐not otherwise specified (29%), angioimmunoblastic T‐cell lymphoma (21%), follicular‐T helper (21%), or anaplastic large‐cell (15%) lymphomas, all were CD30 positive. Overall response was seen in four (29%) patients, and complete response (CR) in two (14%). Most frequent adverse events were infections, and cytopenia. 2‐year progression‐free and overall survival were 14% and 17.5%, respectively. Conclusion Patients with relapsed/refractory PTCL treated with BV‐ICE can achieve CR, but few had a sustained response. This association should preferably be used as a bridge to stem cell transplant or be followed by maintenance therapy.

Domains

Hematology
Fichier principal
Vignette du fichier
Wyngaert et al. - Combination of brentuximab-vedotin and ifosfamide,.pdf (421.52 Ko) Télécharger le fichier
Origin Files produced by the author(s)

Dates and versions

hal-03156375 , version 1 (02-03-2021)

Identifiers

Cite

Zoé van de Wyngaert, Paul Coppo, Pascale Cervera, Bettina Fabiani, Marie‐paule Lemonnier, et al.. Combination of brentuximab‐vedotin and ifosfamide, carboplatin, etoposide in relapsed/refractory peripheral T‐cell lymphoma. European Journal of Haematology, 2020, ⟨10.1111/ejh.13568⟩. ⟨hal-03156375⟩
32 View
235 Download

Altmetric

Share

More